A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD
Clinical trial NCT02371629 · COMPLETED
Trial details
- NCT number
- NCT02371629
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-24
- Primary completion
- 2016-11-16
- Enrollment
- 776
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.